In addition, we identified CD5L as the favorable prognostic factor for overall survival and CSMD1 as the unfavorable prognostic factor for disease-free survival for HCC-A patients and HCC patients in whole. This evidence concerns the gene CD5L and hepatocellular carcinoma.